Novel Coronavirus (SARS-CoV-2/COVID-19)
Summit Healthcare in Arizona taps social media to improve access to behavioral health care during this pandemic.
The national generosity movement known as Giving Tuesday has designated May 5 as #GivingTuesdayNow, a global day of giving in response to the unprecedented need caused by COVID-19.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is enrolling 2,000 U.S. families in a study to help determine the COVID-19 infection rate in U.S. children and their family members, and the share of infected children who develop symptoms.
The Department of Homeland Security and the Cybersecurity and Infrastructure Security Agency have updated their telework guidance to include new guidance on telework best practices, videoconferencing tips, guidance for securing videoconferencing, and specific cybersecurity recommendations for…
The Department of Health and Human Services’ Office of Minority Health May 1 announced it will provide funding to help deliver important COVID-19-related information to racial and ethnic minority, rural and socially vulnerable communities hardest hit by the pandemic.
The Centers for Disease Control and Prevention issued preliminary guidance for the development of forthcoming contact tracing apps that can help slow the spread of COVID-19.
The Food and Drug Administration said it is adopting more stringent standards for COVID-19 antibody tests.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
The AHA sent the Health Resources and Services Administration a letter requesting clarifications for several elements of the COVID-19 Uninsured Program.
The Department of Health and Human Services will begin distributing an additional $22 billion in funds from the Public Health and Social Services Emergency Fund.